Category Archives: Oncology

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

Trying Beyond Meat for the first time

November 12, 2019- by Steven E. Greer, MD

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Internal Medicine, Neurology, Oncology, Pediatrics, Sports medicine, Vascular Surgery | Comments Off on Trying Beyond Meat for the first time

The Breville blender is an essential tool for a meatless diet

November 12, 2019- by Steven E. Greer, MD

Posted in - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Internal Medicine, Neurology, Oncology, Pediatrics, Sports medicine | Comments Off on The Breville blender is an essential tool for a meatless diet

Go Vegan?

November 3, 2019- by Steven E. Greer, MD My diet is much better than it used to be. I eat a lot more plants and almost no red meat. I snack

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, FDA, Gastroenterology and liver, Harvard, Internal Medicine, Oncology, Pediatrics, Sports medicine | Comments Off on Go Vegan?

Daily aspirin once again proves to be of no use and also deadly

Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin. 

Posted in - JAMA, - Pharma, - Policy, Cardiac surgery, Cardiology, Gastroenterology and liver, General surgery, Neurology, Neurosurgery, Oncology, Primary care medicine | Leave a comment

Crystalloid “Balanced Lactated Ringer’s” IV solution is safer to the kidneys

March 1, 2018- Interviewed by Steven E. Greer, MD We interviewed Vanderbilt’s Todd Rice, MD about his NEJM papers that showed crystalloid, or

Posted in - NEJM, Cardiac surgery, Cardiology, Emergency medicine, General surgery, Internal Medicine, Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Pediatrics, Plastic surgery, Sports medicine, Trauma Surgery, Urology, Vanderbilt, Vascular Surgery | Leave a comment

BRAF and MEK combos for melanoma

Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr.  Ribas last year.

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

What is Justice Ruth Bader Ginsburg’s prognosis?

December 21, 2018- by Steven E. Greer, MD Supreme Court Justice Ruth Bader Ginsburd underwent surgery at Memorial Sloan Kettering

Posted in - Opinion, Cardiac surgery, Memorial Sloan-Kettering, Oncology | Leave a comment

TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it

March 23, 2019

Posted in - Pharma, Cardiology, CDC, FDA, Oncology | Comments Off on TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it

Brigham and Women’s Hospital engages in bizarre PR campaign for daily aspirin

 April 21, 2015- By Steven E. Greer, MD Brigham and Women’s Hospital in Boston, part of the Harvard University network of hospitals,

Posted in - Policy, Cardiology, Harvard, Neurology, Oncology | Leave a comment

Once again, daily aspirin is shown to be deadly rather than beneficial

September 16, 2018- by Steven E. Greer, MD The Healthcare Channel has been pounding the table for many years pushing back against the drug

Posted in - NEJM, - Pharma, Cardiac surgery, Cardiology, Gastroenterology and liver, Geriatrics, Internal Medicine, Neurology, Neurosurgery, Oncology, Vascular Surgery | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

CBS News not happy at all that cancer warning added to coffee

March 29, 2018- by Steven E. Greer, MD I have been critical of CBS News for years because they have been in bed with the coffee industry,

Posted in - Opinion, - Policy, Congress, Oncology | Leave a comment

The Daltrey Townshend teenage and young adult cancer center at UCLA

May 4, 2014- Interviewed by Steven E. Greer More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage

Posted in - Opinion, Oncology, Rehab, UCLA | Leave a comment

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

March 19, 2013- Interviewed by Steven E. Greer, MD The upcoming ASCO meeting will be dominated by numerous presentations relating to new

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Interview with Simon Townshend about the Daltrey/Townshend Teen Cancer Program

The Daltrey Townshend teenage and young adult cancer center at UCLA

Posted in Oncology, UCLA | Leave a comment

Bending the cost curve of cancer care

May 25, 2011- Since the approval of Genentech’s costly Avastin in 2004, prominent oncologists have warned that

Posted in - Biotech, - Pharma, CMS, Oncology, VCU | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

November 20, 2017- Interviewed by Steven E. Greer, MD We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment